Back
Cidara Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
62
CDTX
Cidara Therapeutics
Last Price:
13.12
Seasonality Move:
7.06%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.7 | Buy |
| 20-day SMA: | 11.59 | Buy |
| 50-day SMA: | 11.53 | Buy |
| 200-day SMA: | 12.96 | Buy |
| 8-day EMA: | 12.66 | Buy |
| 20-day EMA: | 11.99 | Buy |
| 50-day EMA: | 11.74 | Buy |
| 200-day EMA: | 13.15 | Sell |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 65.74 | Buy |
| Chaikin Money Flow: | -17467 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.44 - 12.42) | Buy |
| Bollinger Bands (100): | (11.01 - 12.73) | Buy |
Cidara Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 13.03 while CDTX 8-day simple moving average is 12.70, which is a Buy signal.
- The stock price of CDTX is 13.03 while Cidara Therapeutics 20-day SMA is 11.59, which makes it a Buy.
- Cidara Therapeutics 50-day simple moving average is 11.53 while CDTX share price is 13.03, making it a Buy technically.
- CDTX stock price is 13.03 and Cidara Therapeutics 200-day simple moving average is 12.96, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a Buy
The current Cidara Therapeutics [CDTX] share price is $13.03. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
91.71M
Price in USD:
13.03
Share Volume:
20.15K
Cidara Therapeutics 52-Week Range
52-Week High:
24.40
52-Week Low:
10.00
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?
The Cidara Therapeutics stock price is 13.03 USD today. -
Will CDTX stock go up or go down?
Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cidara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 13.03 while CDTX 8-day exponential moving average is 12.66, which is a Buy signal.
- The stock price of CDTX is 13.03 while Cidara Therapeutics 20-day EMA is 11.99, which makes it a Buy.
- Cidara Therapeutics 50-day exponential moving average is 11.74 while CDTX share price is 13.03, making it a Buy technically.
- CDTX stock price is 13.03 and Cidara Therapeutics 200-day simple moving average is 13.15, creating a Sell signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $17.37 per share, and an increase next year of $26.43 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
- CDTX Moving Average Covergence Divergence (MACD) indicator is 0.51, suggesting Cidara Therapeutics is a Buy
- Cidara Therapeutics Relative Strength Index (RSI) is 65.74, which suggest Cidara Therapeutics is overbought
- The Bollinger Bands (25) for Cidara Therapeutics is (10.44 - 12.42), which suggest Cidara Therapeutics is a Buy
- The Bollinger Bands (100) for Cidara Therapeutics is (11.01 - 12.73), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.